Related Experiment Video
Updated: Apr 12, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
A novel TBX5 loss-of-function mutation associated with sporadic dilated cardiomyopathy
Wei Zhou1, Lan Zhao2, Jin-Qi Jiang3
1Department of Emergency Medicine, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai 200233, P.R. China.
Insights
Genetic mutations in the TBX5 gene are linked to dilated cardiomyopathy (DCM), a common heart condition. A novel TBX5 mutation, p.A143T, was found to decrease gene activity, increasing susceptibility to sporadic DCM.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Dilated cardiomyopathy (DCM) is the most common primary cardiomyopathy and a leading cause of heart failure and transplantation.
- Genetic factors are implicated in DCM, with mutations identified in over 50 genes, yet the genetic basis remains unknown in many cases.
- TBX5, a T-box transcription factor, is crucial for cardiac development.
Purpose of the Study:
- To investigate the role of the TBX5 gene in sporadic dilated cardiomyopathy.
- To identify novel mutations in TBX5 associated with DCM and elucidate their functional consequences.
Main Methods:
- Sequencing of the TBX5 gene (coding exons and flanking intron-exon boundaries) in 146 unrelated patients with sporadic DCM.
- Functional analysis of identified TBX5 mutations using a dual-luciferase reporter assay.
- Comparison of mutant TBX5 activity with wild-type TBX5 and its interaction with GATA4.
Main Results:
- A novel heterozygous TBX5 mutation, p.A143T, was identified in a patient with sporadic DCM and was absent in 400 control chromosomes.
- The p.A143T mutation, affecting a conserved amino acid, significantly reduced TBX5 transcriptional activity on the atrial natriuretic factor (ANF) gene promoter.
- This mutation abolished the synergistic activation of the ANF promoter by TBX5 and GATA4.
Conclusions:
- This study reports the first association of a TBX5 loss-of-function mutation with increased susceptibility to sporadic DCM.
- The findings provide new insights into the molecular mechanisms underlying DCM pathogenesis.
- The results suggest potential implications for prenatal prophylaxis and personalized treatment strategies for DCM.
Abstract:
Dilated cardiomyopathy (DCM) represents the most prevalent form of primary cardiomyopathy, and is the most common reason for heart transplantation and a major cause of congestive heart failure. Aggregating evidence demonstrates that genetic defects are associated with DCM, and a great number of mutations in >50 genes have been linked to DCM. However, DCM is a genetically heterogeneous disorder and the genetic components underpinning DCM in a significant proportion of patients remain unknown. In the present study, the coding exons and flanking exon‑intron boundaries of the T-Box 5 (TBX5) gene, which encodes a T‑box transcription factor required for normal cardiac development, were sequenced in 146 unrelated patients with sporadic DCM. The functional characteristics of the mutant TBX5 were assayed in contrast to its wild‑type counterpart by using a dual‑luciferase reporter assay system. As a result, a novel heterozygous TBX5 mutation, p.A143T, was identified in a patient with sporadic DCM. The missense mutation, which was absent in 400 control chromosomes, altered the amino acid that was completely conserved evolutionarily among species. Biological analyses revealed that the A143T mutation of TBX5 was associated with significantly decreased transcriptional activity on the promoter of the target gene atrial natriuretic factor (ANF), when compared to its wild‑type counterpart. Furthermore, the A143T mutation abolished the synergistic activation of the ANF promoter between TBX5 and GATA binding protein 4 (GATA4), another crucial transcriptional factor for heart development. To the best of our knowledge, this is the first report on the association of a TBX5 loss‑of‑function mutation with an enhanced susceptibility to sporadic DCM, providing novel insight into the molecular mechanisms of the pathogenesis of DCM and suggesting potential implications for the prenatal prophylaxis and personalized treatment of this commonest primary myocardial disease.
More Related Videos
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Pleiotropy